Page 3 - Negma Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Negma pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Negma Pharmaceuticals Today - Breaking & Trending Today

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 29, 2023 ....

Erik Manting , Mario Brkulj , Corey Davis , Valency Communications , Negma Group , Lifesci Advisors , Swedish Companies Registration Office , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Onvertible Immu Se0005003654 ,

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 28, 2023 ....

Erik Manting , Corey Davis , Mario Brkulj , Valency Communications , Swedish Companies Registration Office , Negma Group , Lifesci Advisors , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Onvertible Immu Se0005003654 ,

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 27, 2023 ....

Erik Manting , Corey Davis , Mario Brkulj , Swedish Companies Registration Office , Valency Communications , Lifesci Advisors , Negma Group , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Onvertible Immu Se0005003654 ,

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 23, 2023 ....

Corey Davis , Erik Manting , Mario Brkulj , Swedish Companies Registration Office , Valency Communications , Negma Group , Lifesci Advisors , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Onvertible Immu Se0005003654 ,

Oxurion NV: Oxurion Receives Transparency Notification from Negma Group

Oxurion Receives Transparency Notification from Negma Group Leuven, BELGIUM, Boston, MA, US - March 2, 2023 - 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing ....

United States , Region Flamande , Dennis Riedl , Maryt Conway , Tom Graney , Michael Dillen , Christopher Brinzey , Conway Communications , Company Annual , Negma Group , Negma Group Ltd , Oxurion Receives Transparency Notification , Euronext Brussels , Belgian Transparency ,